These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30018181)

  • 1. Aging exacerbates mortality of
    Gu H; Liu D; Zeng X; Peng LS; Yuan Y; Chen ZF; Zou QM; Shi Y
    Aging (Albany NY); 2018 Jul; 10(7):1597-1608. PubMed ID: 30018181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lethal pneumonia model of Acinetobacter baumannii: an investigation in immunocompetent mice.
    Zeng X; Gu H; Cheng Y; Jia KR; Liu D; Yuan Y; Chen ZF; Peng LS; Zou QM; Shi Y
    Clin Microbiol Infect; 2019 Apr; 25(4):516.e1-516.e4. PubMed ID: 30583061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia.
    Tang HJ; Chuang YC; Ko WC; Chen CC; Shieh JM; Chen CH; Lee NY; Chiang SR
    Int J Infect Dis; 2012 Jan; 16(1):e34-40. PubMed ID: 22088863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice.
    KuoLee R; Harris G; Yan H; Xu HH; Conlan WJ; Patel GB; Chen W
    Vaccine; 2015 Jan; 33(1):260-7. PubMed ID: 24699469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain.
    Harris G; Kuo Lee R; Lam CK; Kanzaki G; Patel GB; Xu HH; Chen W
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3601-13. PubMed ID: 23689726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratracheal colistin sulfate for BALB/c mice with early pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Chiang SR; Chuang YC; Tang HJ; Chen CC; Chen CH; Lee NY; Chou CH; Ko WC
    Crit Care Med; 2009 Sep; 37(9):2590-5. PubMed ID: 19623044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Immune Responses in
    Sato Y; Tansho-Nagakawa S; Ubagai T; Ono Y
    Front Immunol; 2020; 11():601614. PubMed ID: 33329595
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nosocomial pneumonia due to Acinetobacter baumannii].
    Cisneros-Herreros JM; Garnacho-Montero J; Pachón-Ibáñez ME
    Enferm Infecc Microbiol Clin; 2005 Dec; 23 Suppl 3():46-51. PubMed ID: 16854341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse pneumonia model by Acinetobacter baumannii multidrug resistant strains: Comparison between intranasal inoculation, intratracheal instillation and oropharyngeal aspiration techniques.
    Bergamini G; Perico ME; Di Palma S; Sabatini D; Andreetta F; Defazio R; Felici A; Ferrari L
    PLoS One; 2021; 16(12):e0260627. PubMed ID: 34855837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
    Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
    Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem.
    Joly-Guillou ML; Wolff M; Pocidalo JJ; Walker F; Carbon C
    Antimicrob Agents Chemother; 1997 Feb; 41(2):345-51. PubMed ID: 9021190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia.
    Rodríguez-Hernández MJ; Pachón J; Pichardo C; Cuberos L; Ibáñez-Martínez J; García-Curiel A; Caballero FJ; Moreno I; Jiménez-Mejías ME
    J Antimicrob Chemother; 2000 Apr; 45(4):493-501. PubMed ID: 10747827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic murine models for Acinetobacter baumannii infection.
    Luo G; Spellberg B; Gebremariam T; Bolaris M; Lee H; Fu Y; French SW; Ibrahim AS
    J Antimicrob Chemother; 2012 Jun; 67(6):1439-45. PubMed ID: 22389456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb.
    Garg N; Singh R; Shukla G; Capalash N; Sharma P
    Int J Med Microbiol; 2016 Jan; 306(1):1-9. PubMed ID: 26614015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Protective Efficacy of a Fused OmpK/Omp22 Protein Vaccine Candidate against Acinetobacter baumannii Infection in Mice.
    Guo SJ; Ren S; Xie YE
    Biomed Environ Sci; 2018 Feb; 31(2):155-158. PubMed ID: 29606195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
    Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
    Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic effect of phages on extensively drug-resistant Acinetobacter baumannii-induced sepsis in mice].
    Deng LY; Yang ZC; Gong YL; Huang GT; Yin SP; Jiang B; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):523-8. PubMed ID: 27647067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination induces rapid protection against bacterial pneumonia via training alveolar macrophage in mice.
    Gu H; Zeng X; Peng L; Xiang C; Zhou Y; Zhang X; Zhang J; Wang N; Guo G; Li Y; Liu K; Gu J; Zeng H; Zhuang Y; Li H; Zhang J; Zhang W; Zou Q; Shi Y
    Elife; 2021 Sep; 10():. PubMed ID: 34544549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases.
    Özvatan T; Akalın H; Sınırtaş M; Ocakoğlu G; Yılmaz E; Heper Y; Kelebek N; İşçimen R; Kahveci F
    Respirology; 2016 Feb; 21(2):363-9. PubMed ID: 26635315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
    Montero A; Ariza J; Corbella X; Doménech A; Cabellos C; Ayats J; Tubau F; Borraz C; Gudiol F
    J Antimicrob Chemother; 2004 Dec; 54(6):1085-91. PubMed ID: 15546972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.